{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:17:24Z","timestamp":1793398644454,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.amjcard.2015.09.047","type":"journal-article","created":{"date-parts":[[2015,10,25]],"date-time":"2015-10-25T11:18:34Z","timestamp":1445771914000},"page":"61-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Racial Differences in Quality of Anticoagulation Therapy for Atrial Fibrillation (from the TREAT-AF Study)"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3054-6576","authenticated-orcid":false,"given":"Celina","family":"Yong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Azarbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy","family":"Abnousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire T.","family":"Than","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya J.","family":"Ullal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciaran S.","family":"Phibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Frayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Michael","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supriya","family":"Shore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Mahaffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mintu P.","family":"Turakhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2015.09.047_bib1","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1161\/01.cir.0000441139.02102.80","article-title":"Heart disease and stroke statistics\u20132014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.09.047_bib2","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2015.09.047_bib3","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.107.750000","article-title":"Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range","volume":"118","author":"Connolly","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.09.047_bib4","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0140-6736(10)61194-4","article-title":"Efficacy and safety of dabigatran compared with warfarin at different levels of international normalized ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial","volume":"376","author":"Wallentin","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2015.09.047_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ahj.2012.10.010","article-title":"Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: the Retrospective Evaluation and Assessment of Therapies in AF (TREAT-AF) study","volume":"165","author":"Turakhia","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2015.09.047_bib6","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jacc.2014.03.060","article-title":"Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study","volume":"64","author":"Turakhia","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.09.047_bib7","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/01.mlr.0000244657.90074.b7","article-title":"Veterans' access to and use of Medicare and Veterans Affairs health care","volume":"45","author":"Hynes","year":"2007","journal-title":"Med Care"},{"key":"10.1016\/j.amjcard.2015.09.047_bib8","series-title":"Assessing Race and Ethnicity. 2013 VIReC Database and Methods Cyber Seminar Series","author":"Mor","year":"2013"},{"key":"10.1016\/j.amjcard.2015.09.047_bib9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/01.mlr.0000207433.70159.23","article-title":"Racial\/ethnic differences in diabetes care for older veterans: accounting for dual health system use changes conclusions","volume":"44","author":"Halanych","year":"2006","journal-title":"Med Care"},{"key":"10.1016\/j.amjcard.2015.09.047_bib10","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1345\/aph.1H018","article-title":"Measurement of persistence in pharmacy administrative databases: a proposal for standard definitions and preferred measures","volume":"40","author":"Hess","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjcard.2015.09.047_bib11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/pds.1230","article-title":"Methods for evaluation of medication persistence and persistence using automated databases","volume":"15","author":"Andrade","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.amjcard.2015.09.047_bib12","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/00005650-198808000-00007","article-title":"A\u00a0general method of compliance assessment using centralized pharmacy records. Description and validation","volume":"26","author":"Steiner","year":"1988","journal-title":"Med Care"},{"key":"10.1016\/j.amjcard.2015.09.047_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1185\/03007995.2013.766164","article-title":"Revisiting the medication possession ratio threshold for persistence in lipid management","volume":"29","author":"Watanabe","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.amjcard.2015.09.047_bib14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A\u00a0method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjcard.2015.09.047_bib15","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCOUTCOMES.110.937680","article-title":"Warfarin discontinuation after starting warfarin for atrial fibrillation","volume":"3","author":"Fang","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjcard.2015.09.047_bib16","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jacc.2008.01.006","volume":"51","author":"Estes","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.09.047_bib17","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/jama.290.20.2685","article-title":"Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?","volume":"290","author":"Go","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2015.09.047_bib18","series-title":"VHA Directive 2009-003. Anticoagulation Therapy Management","year":"2009"},{"key":"10.1016\/j.amjcard.2015.09.047_bib19","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2009-12-255992","article-title":"Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups","volume":"115","author":"Limdi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.amjcard.2015.09.047_bib20","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/clpt.2010.322","article-title":"The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans","volume":"89","author":"Perera","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjcard.2015.09.047_bib21","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa1310669","article-title":"A\u00a0pharmacogenetic versus a clinical algorithm for warfarin dosing","volume":"369","author":"Kimmel","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2015.09.047_bib22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1477-9560-6-6","article-title":"Examining warfarin underutilization rates in patients with atrial fibrillation: detailed chart review essential to capture contraindications to warfarin therapy","volume":"6","author":"Srivastava","year":"2008","journal-title":"Thromb J"},{"key":"10.1016\/j.amjcard.2015.09.047_bib23","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1161\/STROKEAHA.109.573907","article-title":"Racial disparities in awareness and treatment of atrial fibrillation: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study","volume":"41","author":"Meschia","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2015.09.047_bib24","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1111\/j.1538-7836.2010.03996.x","article-title":"Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA)","volume":"8","author":"Rose","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.amjcard.2015.09.047_bib25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/1062860614526282","article-title":"Explaining racial disparities in anticoagulation control: results from a study of patients at the Veterans Administration","volume":"30","author":"Rao","year":"2015","journal-title":"Am J Med Qual"},{"key":"10.1016\/j.amjcard.2015.09.047_bib26","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1378\/chest.13-0054","article-title":"Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT\u2082R\u2082 score","volume":"144","author":"Apostolakis","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2015.09.047_bib27","doi-asserted-by":"crossref","first-page":"e000521","DOI":"10.1161\/JAHA.113.000521","article-title":"Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results form the ROCKET AF trial","volume":"3","author":"Piccini","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2015.09.047_bib28","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1161\/CIRCULATIONAHA.112.142158","volume":"127","author":"Wallentin","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.09.047_bib29","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.amjmed.2014.07.024","article-title":"Bleeding rates in Veterans Affairs patients with atrial fibrillation who switch from warfarin to dabigatran","volume":"127","author":"Vaughan","year":"2014","journal-title":"Am J Med"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914915020858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914915020858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T19:08:33Z","timestamp":1567278513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914915020858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0002914915020858"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2015.09.047","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial Differences in Quality of Anticoagulation Therapy for Atrial Fibrillation (from the TREAT-AF Study)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2015.09.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}